Grants-in-Aid

We advertise for applications for Grants-in-Aid at the start of each year (for funding to start in January the following year).

Grants-in-Aid support research for 1 to 3 years. They're awarded based on each project's:

  • relevance to cancer,
  • excellence,
  • the value of the research, and
  • the researcher's capacity to successfully complete the research described in the application.

All applications go through a rigorous peer-review process. The state Cancer Councils work in partnership with the National Health and Medical Research Council, which provides us with assessments and rankings.

In 2018 Cancer Council Victoria spent $3.9 million on Grants-in-Aid, including funding for low survival cancers research from the Victorian Cancer Agency. Current recipients are listed below.


 

Prof Robin Anderson, Prof Robert Parton
Olivia Newton-John Cancer Research Institute
Loss of a protein called caveolin-1 in host cells surrounding tumour results in promotion of breast cancer metastasis (2019-2021)

 

Dr Nicholas Clemons, Prof Wayne Phillips, Dr Gang Chen, Dr Cuong Duong, A/Prof Sarah-Jane Dawson, Prof David Watson, Prof Reginald Lord, A/Prof David Wang
The University of Melbourne
Development of a simple blood test to guide treatment decisions for patients with oesophageal cancer (2019-21)

 

Dr James Dowty, A/Prof Daniel Buchanan, Prof Ingrid Winship, A/Prof Robert Waterland, Dr Jihoon Joo, Prof Mark Jenkins, Prof Melissa Southey
The University of Melbourne
Heritable methylation marks associated with colorectal cancer risk (2019-2020)

 

Dr Moritz Eissmann, Prof Matthias Ernst, Prof Alex Boussioutas
La Trobe University
Testing antibodies inhibiting IL33-signalling against gastric cancer (2019-21)

 

A/Prof Thomas Gebhardt
The University of Melbourne
Long-term immune control of clinically invisible melanoma (2019-2021)

 

Dr Catherine Granger
The University of Melbourne
A randomised control trial to evaluate the effect of exercise and self-management on outcomes of people with operable lung cancer (2019-21)

 

Dr Lev Kats, Prof Ricky Johnstone
Peter MacCallum Cancer Centre
Development of new targeted therapies for acute myeloid leukaemia (2019-2021)

 

Dr Simon Keam
Peter MacCallum Cancer Centre
Understanding and avoiding radiation resistance in prostate cancer using personalised medicine (2019-2021)

 

Prof John Mariadason
Olivia Newton-John Cancer Research Institute
A new way to treat bowel cancer (2019-2021)

 

Prof Neil O'Brien-Simpson, A/Prof Andrea O'Connor, Prof Michael McCullough, Dr Jason Lenzo
The University of Melbourne
Under the tongue vaccine for oral and oesophageal cancers (2019-2021)

 

Dr Lorraine O'Reilly, Prof Andreas Strasser, A/Prof Nicholas Huntington
The Walter and Eliza Hall Institute of Medical Research
Combating immunotherapy toxicities to guide safer gastric cancer therapy using a new pre-clinical model (2019-2021)

 

A/Prof Louise Purton, A/Prof Carl Walkley, Dr Meaghan Wall, Dr Helene Jousset
St Vincent's Institute of Medical Research
Identifying better therapies for blood cell cancers (2019-2021)

 

Prof Andrew Scott, A/Prof Hui Gan, Prof Weisan Chen
Olivia Newton-John Cancer Research Institute
Improving GBM Response to Antibody-Drug Conjugate Therapy (2019-2020)

 

Prof Matthew J. Watt, Dr Renea A. Taylor, A/Prof Daniel Nomura
The University of Melbourne
Targeting fatty acid metabolism for prostate cancer therapy (2019-2021)

 

Dr Ashwini Chand, Prof Matthias Ernst, Prof Michael Parker
La Trobe University
Repurposing drugs for the treatment of gastrointestinal cancers (2018-20)

 

A/Prof Phillip Darcy, Dr Paul Beavis, Prof Dale Godfrey
Peter MacCallum Cancer Centre
Investigating the role of a novel immune cell subset in cancer (2018-20)

 

Dr Daniel Gough, Prof David Watkins, Dr Kate Sutherland, A/Prof Jake Shortt
Hudson Institute of Medical Research
Identifying new treatments for platinum resistant Small Cell Lung Cancer (2018-20) 

 

A/Prof Daniel Gray, Prof David Huang, Prof Andrew Roberts, Prof Terence Speed
The Walter and Eliza Hall Institute of Medical Research
Understanding how new therapies target blood cancer (2018-20)

 

A/Prof Craig Harrison, Dr Paul Gregorevic, A/Prof Jose Garcia
Monash University
Towards precision medicine for cancer cachexia (2018-20)

 

A/Prof Christine Hawkins, Prof Andrew Scott, A/Prof Carl Walkley
La Trobe University
Testing new drugs for bone cancer (2018-20)

 

A/Prof Thomas John, Prof Andrew Scott, A/Prof Hui Gan
The Olivia Newton-John Cancer Research Institute
New treatments for mesothelioma (2018-20)

 

Prof Ricky Johnstone, A/Prof Jake Shortt
Peter MacCallum Cancer Centre
Targeting transcriptional addiction for cancer therapy (2018-20)

 

Dr Gemma Kelly, Dr Marco Herold, Dr MaryAnn Anderson
The Walter and Eliza Hall Institute of Medical Research
Investigating a novel anti-cancer agent targeting MCL-1 for the treatment of haematological cancers (2018-20)

 

Prof Christina Mitchell, Prof Catriona McLean
Monash University
Regulation of phosphoinositide 3-phosphate tumour suppressor activity (2018-20)

 

Dr Donia Moujalled
Monash University
New treatments for Acute lymphoblastic leukaemia (2018-20)

 

Prof David Ritchie, Dr Nicholas Huntington
The University of Melbourne
Inhibiting immune cell function to improve stem cell transplant outcomes in leukaemia (2018-20)

 

Prof Tony Tiganis, Prof Catriona McLean
Monash University
Determining how liver cancer develops in obesity (2018-20)

 

Dr Urmi Dhagat, Dr Sophie Broughton, Prof Michael Parker, A/Prof Louise Purton
The University of Melbourne (2018-2019); St Vincent's Institute of Medical Research (2017-2018)
How does the protein hormone interleukin-3 regulate cell signalling in leukaemic cells? (2017-19) 

 

A/Prof Hui Gan, Prof Andrew Scott, Prof John Mariadason, A/Prof Elgene Lim, Prof Niall Tebbutt
La Trobe University
Anti-EGFR drug conjugates for the treatment of colorectal and breast cancer  (2017-19) 

 

Prof Suzanne Garland, Prof Sepehr Tabrizi, A/Prof Richard Hillman, Dr Alyssa Cornall, Dr Fengyi Jin, Dr Jennifer Roberts, Dr Isobel Poynten, Dr Monica Molano, Dr Dorothy Machalek
The University of Melbourne
Assessment of potential tests for anal cancer screening (2017-19)

 

Prof John Hopper, Dr Daniel Schmidt, Dr Enes Makalic, Dr Carmel Apicella, Dr Louise Keogh, Dr Helen Frazer, Dr Pierre-Antoine Dugue, Dr Ralph Highnam, Mr Kevin Nguyen, Dr Jill Evans
The University of Melbourne
Automated measures that predict risk and masking of breast cancer  (2017-19)

 

Dr Peter Janes, Prof Andrew Scott, A/Prof Thomas John
Monash University (2017-2018); La Trobe University (2018-2019)
Targeted antibody therapy for malignant mesothelioma 
Lyall Watts Mesothelioma Research Grant (2017-2019)

 

Dr Ian Majewski, Prof David Huang, Prof Andrew Roberts
The Walter and Eliza Hall Institute of Medical Research
Targeting cell survival pathways to treat cancer (2017-19) 

 

Dr Kate Murphy, Prof John Silke, Prof Gordon Lynch, Prof Leanne Delbridge
The University of Melbourne
A novel treatment for heart failure in cancer and with chemotherapy (2017-19)

 

Dr Lan Nguyen
Monash University
Elucidating the dual functions of YAP in breast cancer (2017-19) 

 

Dr Belinda Parker, A/Prof Phil Darcy
La Trobe University
Predicting the benefit of therapies for patients with triple negative breast cancer (2017-19)

 

A/Prof Helena Richardson, A/Prof Patrick Humbert, Prof Josef Penninger
La Trobe University
Determining how a novel protein controls cell shape and cancer progression  (2017-19)

 

Dr Adam Uldrich, Dr Daniel Pellicci, Dr Ilia Voskoboinik
The University of Melbourne
Examining the anti-cancer properties of gamma delta T cells (2017-19) 
A/Prof Carl Walkley, A/Prof Wallace Langdon, Dr Meaghan Wall, Dr Alistair Chalk
St Vincent's Institute of Medical Research
Understanding how blood cancers form (2017-19) 

 

A/Prof Kieran Harvey, Dr Nicola Waddell, A/Prof Kaylene Simpson
Peter MacCallum Cancer Centre
What causes mesothelioma and how can we treat it?
Lyall Watts Mesothelioma Research Grant (Sept 2016 - Aug 2019)

 

Dr Nicole Haynes, Prof Ricky Johnstone, A/Prof Sherene Loi
The University of Melbourne (Peter MacCallum Cancer Centre)
Targeting HER2+ breast cancer with novel combination therapies (2016-18)

 

Dr Peter Janes, Prof Dimitar Nikolov, Dr Elgene Lim
Monash University
Novel therapeutic antibodies to fight drug resistant breast cancers  (2016-18)

 

Prof Stephen Nutt, A/Prof Lynn Corcoran
The Walter and Eliza Hall Institute of Medical Research
Exploring new molecular targets on plasma cells as therapies for multiple myeloma  (2016-18)

 

Dr Gretchen Poortinga, Prof Grant McArthur, Prof Ross Hannan
Peter MacCallum Cancer Centre
Understanding how cancer cells become resistant to a novel treatment of blood cancers (2016-18) 

 

A/Prof Louise Purton, Dr Meaghan Wall, Dr Carl Walkley
St Vincent's Institute of Medical Research
Identifying better treatments for blood cell cancers (2016-18)

 

Prof Jamie Rossjohn, Prof Andrew Brooks
Monash University
Exploring how tumour cells are recognised by Natural Killer cells (2016-18)

 

Dr Karen Sheppard, Prof Grant McArthur
Peter MacCallum Cancer Centre
Understanding why melanomas stop responding to therapy that inhibits cells from growing  (2016-18)

 

Prof Andreas Strasser, Dr Daniel Gray
The Walter and Eliza Hall Institute of Medical Research
How does competition between cells impact tumour development (2016-18)

 

Prof Jose Villadangos, Prof William Heath
The University of Melbourne
Improving cancer killing with live cell therapy (2016-18)

 

Dr Florian Wiede
Monash University (2016-2017); The University of Melbourne (2018)
Defining a novel immunotherapy for more effective cancer treatment (2016-18)